Filing Details
- Accession Number:
- 0001567619-20-017574
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-05 16:43:54
- Reporting Period:
- 2020-10-01
- Accepted Time:
- 2020-10-05 16:43:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1533743 | Processa Pharmaceuticals Inc. | PCSA | Pharmaceutical Preparations (2834) | 451539785 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1681718 | H James Stanker | C/O Processa Pharmaceuticals, Inc. 7300 Coca Cola Drive, Suite 106 Hanover MD 21076 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-10-01 | 6,000 | $2.10 | 47,248 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
